Creative Medical Technology Holdings (Creative Medical Technology Holdings) Gross-Profit-to-Asset % : 0.07% (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Creative Medical Technology Holdings Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Creative Medical Technology Holdings's annualized Gross Profit for the quarter that ended in Dec. 2023 was $0.01 Mil. Creative Medical Technology Holdings's average Total Assets over the quarter that ended in Dec. 2023 was $11.61 Mil. Therefore, Creative Medical Technology Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 0.07%.

Creative Medical Technology Holdings Gross-Profit-to-Asset % Historical Data

The historical data trend for Creative Medical Technology Holdings's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings Gross-Profit-to-Asset % Chart

Creative Medical Technology Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

23.81

18.25

0.67

0.39

0.03

Creative Medical Technology Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															0.25	-	-	0.12	0.07

Competitive Comparison of Creative Medical Technology Holdings's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Creative Medical Technology Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creative Medical Technology Holdings's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Creative Medical Technology Holdings's Gross-Profit-to-Asset % falls into.

Creative Medical Technology Holdings Gross-Profit-to-Asset % Calculation

Creative Medical Technology Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	0.005	/	( (19.186	+	10.715)	/ 2 )
	=	0.005	/	14.9505
	=	0.03 %

Creative Medical Technology Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	0.008	/	( (12.514	+	10.715)	/ 2 )
	=	0.008	/	11.6145
	=	0.07 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Creative Medical Technology Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Creative Medical Technology Holdings (Creative Medical Technology Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Creative Medical Technology Holdings Inc (NAS:CELZ) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

211 E Osborn Road, Phoenix, AZ, USA, 85012

Website

https://www.creativemedicaltechnology.com

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Executives

Timothy Warbington	director, 10 percent owner, officer: President & CEO	211 E. OSBORN ROAD, PHOENIX AZ 85012
Michael H. Finger	director	1551 N. DIANE ST., MESA AZ 85203-3850
Susan H Snow	director	26 SEDGE FERN DRIVE, HILTON HEAD SC 29926
Bruce Steven Urdang	director	5171 E. HAWTHORNE DR., FLAGSTAFF AZ 86004-7377
Thomas Ichim	director	211 E. OSBORN RD, PHOENIX AZ 85012
Creative Medical Health Inc.	10 percent owner	211 E. OSBORN RD, PHOENIX AZ 85012
Timothy Herbst	10 percent owner	2031 W. PEORIA AVE., SUITE 250, PHOENIX AZ 85029
Amit Nilkanth Patel	director	1040 CHARTWELL CT., SALT LAKE CITY UT 84121
Donald Dickerson	director, officer: CFO & Sr.VP	822 VERA STREET, SOLANA BEACH CA 92075
Steven L White	director, officer: President,Secretary,Treasurer	386 NORTH 210 EAST, MAPLETON UT 84664